Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a2/d0/2e/a2d02e38-ee60-a2a4-bf5c-e6d951b93b39/mza_3048579604930026653.jpg/600x600bb.jpg
ATTD: Advanced Technologies and Treatments for Diabetes
ATTD on UNLOK
41 episodes
1 day ago
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Show more...
Life Sciences
Science
RSS
All content for ATTD: Advanced Technologies and Treatments for Diabetes is the property of ATTD on UNLOK and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43275051/43275051-1753099234338-3eab05c1c6886.jpg
Patient Selection Criteria for Long-Acting Insulin Therapy
ATTD: Advanced Technologies and Treatments for Diabetes
38 minutes 3 seconds
3 months ago
Patient Selection Criteria for Long-Acting Insulin Therapy

In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.

They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.

Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.

She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care Practice.

If you'd like to dive deeper into today’s topic, don’t miss our workshop video: “Patient Selection and Initiation of Long-Acting Insulin Therapy” on the ATTD Education Portal, where Dr. Rodolfo Galindo, Dr. Amit Gupta, Dr. Medha Munshi, Prof. Concetta Irace, and Prof. Raffaella Buzzetti explore two real-world case studies and share expert strategies to guide clinical decisions.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.